Log In
Print
BCIQ
Print
Print this Print this
 

PEG-IFN lambda (peginterferon lambda) (PEG-rIL-29)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionPegylated recombinant IL-29
Molecular Target Interleukin-29 (IL-29) (IFNL1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today